Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast ...
Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies: Pasadena, California Thursday, December 11, 2025, 12:00 ...
Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market: Switzerland Thursday, December 11, 2025, 11:00 Hrs ...
Pharmexcil announces election for one-third of the members of the CoA for 2025–26: Shardul Nautiyal, Mumbai Thursday, December 11, 2025, 12:10 Hrs [IST] In line with Articles 24 ...
US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer: London, UK Thursday, December 11, 2025, 09:00 Hrs [IS ...
WHO & European Commission’s HERA sign €3.5 mn agreement to expand partnership to combat antimicrobial resistance under EU4Health programme: Geneva Thursday, December 11, 2025, ...
Only 192 applications approved under RPTUAS to upgrade existing units to revised Schedule M standards: Gireesh Babu, New Delhi Thursday, December 11, 2025, 08:00 Hrs [IST] Even as ...
AICDF pushes for prosecution of pharma houses for decade-long non-compliance: Peethaambaran Kunnathoor, Chennai Thursday, December 11, 2025, 08:00 Hrs [IST] The All India Chemists ...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has sought pharma industry inputs to usher in industry engagement towards strengthening India-United Kingdom (UK) Comprehensive ...
Indian govt initiates discussion to fast-track approval for pharmaceuticals in Taiwan: Shardul Nautiyal, Mumbai Thursday, December 11, 2025, 08:00 Hrs [IST] The Government of Indi ...
RGUHS fee hike for pharmacy, medical & nursing education undermines State’s health education ecosystem: Nandita Vijayasimha, Bengaluru Thursday, December 11, 2025, 08:00 Hrs [IS ...
Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study: Basel Wednesday, December 10, 2025, 18:00 Hrs [IST] Roch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results